MVF has ticked up a few cents since the VRT result was announced.
It's as though the market expects MVF to produce a similarly decent result, however VRT's increased margins on flat revenue imply that MVF's share of the premium IVF pie will have diminished, with both companies losing overall market share to low cost competitors.
Hope I'm wrong. (disclosure - MVF holder)
Ann: Appendix 4E & Annual Report 30 June 2018, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
